Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
SALES / VALUECompleted eBay sales; useful support, especially for the global market.
Transaction-based price; use it as the valuation baseline.
Transaction-based price; use it as the valuation baseline.
Seller asking prices. They show availability but do not prove demand.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-11-06 | List | €13.25 | -33.8% |
| 2026-11-06 | Sold | €11.82 | -1.4% |
| 2026-11-06 | TCG | $17.14 | — |
| 2026-11-05 | Sold | €11.99 | -2.6% |
| 2026-11-05 | TCG | $17.14 | +0.9% |
| 2026-11-04 | Sold | €12.31 | -3.0% |
| 2026-11-04 | TCG | $16.98 | — |
| 2026-11-04 | EB | $16.50 | +10.1% |
| 2026-11-03 | Sold | €12.69 | — |
| 2026-11-03 | TCG | $16.98 | +0.4% |
| 2026-11-03 | EB | $14.99 | -23.7% |
| 2026-11-02 | Sold | €12.69 | -1.7% |
| 2026-11-02 | TCG | $16.91 | -0.5% |
| 2026-11-01 | Sold | €12.91 | +0.4% |
SV02: Paldea Evolved / #209/193/Holofoil
France: lowest · United Kingdom: below average · EU average €16.07Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
NMRAW | $17.14 | $17.14 | $17.14 | +0.6% | >5 | |
AggregatedRAW | €11.82 | €4.98 | €15.74 | -8.1% | >5 | |
LPRAW | $16.25 | $16.25 | $16.25 | -8.1% | >5 | |
DMGRAW | $10.92 | $10.92 | $10.92 | -8.1% | >5 | |
MPRAW | $13.62 | $13.62 | $13.62 | -8.1% | >5 | |
HEAVILY PLAYEDRAW | $11.94 | $11.94 | $11.94 | -8.1% | >5 | |
MINTRAW | €11.82 | €4.98 | €15.74 | -8.1% | >5 |
Explore Arctibax #209/193, Holofoil from SV02: Paldea Evolved, with 2030 price records for the US market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.